ArticleEuropean respiratory review : an official journal of the European Respiratory Society2014
Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients.
Article in European respiratory review : an official journal of the European Respiratory Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Novel Co-Occurrence of GermlineInternational journal of molecular sciences · 2026Article
- Prevalence and Clinical Implications of Somatic and Germline EGFR Mutations in Patients with Non-Small-Cell Lung Cancer.Cancers · 2026Review
- Lung squamous cell carcinoma with germline EGFR P848L mutation: a case report.Annals of medicine and surgery (2012) · 2026Article
- The changing treatment landscape of EGFR-mutant non-small-cell lung cancer.Nature reviews. Clinical oncology · 2025Review
- Germline EGFR mutations in lung cancer (Review).Oncology letters · 2023Review
- Case report: identification of EGFR R776H and FANCE R381H germline mutations in a patient with multiple pulmonary nodules.Journal of cancer research and clinical oncology · 2023Article
- Identification of the Unique Clinical and Genetic Features of Chinese Lung Cancer Patients WithFrontiers in oncology · 2021Article
- The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility.Translational lung cancer research · 2020Article
- Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model.FEBS open bio · 2019Article
- Inherited lung cancer syndromes targeting never smokers.Translational lung cancer research · 2018Review
- NovelJCO precision oncology · 2018Article
- Prevalence of EGFR Mutations in Lung Cancer in Uruguayan Population.Journal of cancer epidemiology · 2017Article
- Exome sequencing reveals germline gain-of-functionCold Spring Harbor molecular case studies · 2016Article
- Germline mutations predisposing to non-small cell lung cancer.Familial cancer · 2015Review
- Real-World Evidence for First-Line afatinib in Advanced Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations Other than G719X/L861Q/S768I.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.